<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: Insulin Like Growth Factor (IGF I) as the one of the strongest growth factors which can affect <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> development including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>IGF I induces processes of the cells growth and division </plain></SENT>
<SENT sid="2" pm="."><plain>It regulates cells cycle and inhibits <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>There is limited data about correlation between IGF I and staging of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of the study was estimation of the clinical usefulness of IGF I concentration in the serum of the patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>MATERIAL AND METHODS: We have examined 125 individuals with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The age range was 36 to 92 years </plain></SENT>
<SENT sid="7" pm="."><plain>They have been operated in the 2nd Departament of The Gastrointestinal Surgery of the Medical University in Bia≈Çystok </plain></SENT>
<SENT sid="8" pm="."><plain>Serum concentration of the IGF I have been estimated using immunoassay ELISA before and after operation </plain></SENT>
<SENT sid="9" pm="."><plain>Correlation between serum level of IGF I and clinicopathologic features: age, gender, localisation of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>, TNM stage of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, histological type and histological grade (G) of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> have been estimated </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: Our study revealed statistically significant increased serum concentration of IGF I in patients with locally advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (pT3 and pT4) comparing to less advanced (pT2) The investigations showed higher serum concentration of IGF I in patients with poorly differentiated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (G3) than in moderately differentiated </plain></SENT>
<SENT sid="11" pm="."><plain>Similarly higher serum concentration of IGF I were found in male, in patients older than 60 years and in mucigenous <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Our results indicated that IGF I can be one of the factors of the prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development </plain></SENT>
</text></document>